xanthone has been researched along with mangostin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Banumathi, B; Gopalakrishnan, G; Suresh, G | 1 |
| Afonso, C; Almeida, T; Azevedo, C; Correia-da-Silva, M; Freitas, S; Moreira, J; Palmeira, A; Pinto, M; Sousa, E; Urbatzka, R; Vasconcelos, V | 1 |
| Gao, B; Jia, Y; Jiang, K; Jiang, L; Meng, T; Niu, A; Wang, J; Yu, J; Zhou, L | 1 |
| Hasmeda, M; Lu, ZX; Mahabusarakam, W; Polya, GM; Ternai, B; Ternai, PC | 1 |
| Arakawa, T; Nakahata, N; Nakatani, K; Ohizumi, Y; Yasuda, H | 1 |
| Devi Sampath, P; Vijayaraghavan, K | 1 |
| Chitchumroonchokchai, C; Clinton, SK; Failla, ML; Kinghorn, AD; Li, J; Nontakham, J; Riedl, KM; Suksumrarn, S; Thomas-Ahner, JM | 1 |
| Falsetta, ML; Gonzalez-Begne, M; Hwang, G; Koo, H; Nguyen, PT | 1 |
| Biagiotti, M; Morelli, CF; Pappalardo, VM; Rabuffetti, M; Speranza, G | 1 |
| Cai, E; Hou, Y; Lei, D; Liu, S; Tang, G; Tang, Q; Wang, S; Zhang, J; Zhang, L; Zhao, Y | 1 |
| Abdulla, MA; Al-Jashamy, K; Aldoubi, AF; Dehghan, F; Hashim, NM; Hassandarvish, P; Ibrahim, MY; Karimian, H; Mohan, S; Nordin, N; Omer, FAA; Salim, LZA | 1 |
| Abdelwahab, SI; Mohan, S; Syam, S; Thangavel, N | 1 |
12 other study(ies) available for xanthone and mangostin
| Article | Year |
|---|---|
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
Topics: Alkylation; Alternaria; Antifungal Agents; Fusarium; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mitosporic Fungi; Plants, Medicinal; Xanthines | 1997 |
Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Anti-Obesity Agents; Antioxidants; Drug Evaluation, Preclinical; Lipid Metabolism; Mice; Obesity; Polyphenols; Zebrafish | 2018 |
Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Structure; Phosphoglycerate Mutase; Structure-Activity Relationship; Xanthones | 2021 |
Inhibition of eukaryote protein kinases and of a cyclic nucleotide-binding phosphatase by prenylated xanthones.
Topics: Animals; Antifungal Agents; Chickens; Cyclic Nucleotide-Regulated Protein Kinases; Enzyme Inhibitors; Gizzard, Avian; Myosin-Light-Chain Kinase; Protein Kinase Inhibitors; Protein Kinases; Rats; Solanum tuberosum; Structure-Activity Relationship; Triticum; Xanthenes; Xanthones | 1998 |
Inhibition of cyclooxygenase and prostaglandin E2 synthesis by gamma-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells.
Topics: Animals; Arachidonic Acid; Calcimycin; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Drug Interactions; Garcinia mangostana; Glioma; HIV Protease Inhibitors; Isoenzymes; Membrane Proteins; Microsomes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Synthesis Inhibitors; Rats; Tumor Cells, Cultured; Xanthenes; Xanthones | 2002 |
Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Garcinia mangostana; Isoproterenol; Lipid Peroxides; Male; Myocardial Infarction; Phytotherapy; Rats; Rats, Wistar; Xanthones | 2007 |
Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites.
Topics: Animals; Antineoplastic Agents; beta Catenin; Beverages; Biomarkers; Cell Proliferation; Cell Survival; Colonic Neoplasms; Diet; Female; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Tissue Distribution; Xanthones; Xenograft Model Antitumor Assays | 2013 |
α-Mangostin disrupts the development of Streptococcus mutans biofilms and facilitates its mechanical removal.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Biofilms; Biomass; Durapatite; Gene Expression Regulation, Bacterial; Phosphotransferases; Polysaccharides; Saliva; Streptococcus mutans; Stress, Mechanical; Vietnam; Virulence; Xanthones | 2014 |
Chemistry of α-mangostin. Studies on the semisynthesis of minor xanthones from Garcinia mangostana.
Topics: Acylation; Alkylation; Fruit; Garcinia mangostana; Molecular Structure; Xanthones | 2015 |
A Method of Effectively Improved α-Mangostin Bioavailability.
Topics: Administration, Oral; Animals; Biological Availability; Female; Fruit; Garcinia mangostana; Male; Plant Extracts; Plant Oils; Rats; Rats, Sprague-Dawley; Tissue Distribution; Xanthones | 2016 |
Beta-mangostin demonstrates apoptogenesis in murine leukaemia (WEHI-3) cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clusiaceae; Leukemia; Liver; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Reactive Oxygen Species; Spleen; Xanthones | 2017 |
An anti-inflammatory molecular mechanism of action of α-mangostin, the major xanthone from the pericarp of Garcinia mangostana: an in silico, in vitro and in vivo approach.
Topics: Animals; Anti-Inflammatory Agents; Computer Simulation; Cyclooxygenase 2; Fruit; Garcinia mangostana; Humans; Inflammation; Interleukin-1beta; Macrophages; Male; Mice; Mice, Inbred ICR; NF-kappa B; Plant Extracts; RAW 264.7 Cells; Tumor Necrosis Factor-alpha; Xanthones | 2018 |